High‐density lipoprotein‐associated sphingosine‐1‐phosphate activity in heterozygous familial hypercholesterolaemia
- 30 November 2016
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 47 (1) , 38-43
Abstract
Patients with heterozygous familial hypercholesterolemia (FH) suffer from high plasma cholesterol and an environment of increased oxidative stress. We examined its potential effects on high density lipoprotein (HDL) associated sphingosine-1-phosphate (S1P) content (HDL-S1P) and HDL-mediated protection against oxidative stress, both with and without statin treatment. In a case-control study, HDL was isolated from 12 FH patients with and without statin treatment and from 12 healthy controls. The HDL-S1P content and the capacity of HDL to protect cardiomyocytes against oxidative stress in vitro were measured. HDL associated S1P was significantly correlated with cell protection, but not with HDL-cholesterol or apolipoprotein AI. The latter did not correlate with HDL-mediated cell protection. Neither the HDL-S1P content nor HDL protective capacity differed between non-treated FH patients and controls. The relative amounts of apolipoprotein AI and apolipoprotein M were similar between controls and FH patients. Statin treatment had no effect on any of these measures. The FH environment is not detrimental to HDL-S1P content or HDL-S1P mediated cell protection. Statin treatment does not modulate HDL function in this regard.Keywords
Funding Information
- Fondation Gustave et Simone Prévot
This publication has 23 references indexed in Scilit:
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapyCritical Reviews in Clinical Laboratory Sciences, 2013
- Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial BarrierJournal of Biological Chemistry, 2012
- Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosisCoronary Artery Disease, 2012
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein MProceedings of the National Academy of Sciences, 2011
- Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemiaClinical Biochemistry, 2010
- Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery diseaseBasic Research in Cardiology, 2010
- A catalogue of reporting guidelines for health researchEuropean Journal of Clinical Investigation, 2009
- Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosisCardiovascular Research, 2009
- Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediatorAmerican Journal of Physiology-Cell Physiology, 2007